Status and phase
Conditions
Treatments
About
To explore the safety and efficiency of adenovirus-hepatocyte growth factor(Ad-HGF) treatment in ischemic heart disease.
Full description
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
40 participants in 1 patient group
Loading...
Central trial contact
Dingguo Zhang, PhD.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal